Rare Diseases

Rare diseases are often genetic in nature, as reflected by the supplied focus on genetic variation, genome, alleles, exome, and quantitative trait loci. The grounding does not support a single common cause across the category, since rare diseases comprise a heterogeneous group.

The biological mechanisms are heterogeneous and depend on the specific rare disease. The supplied grounding supports a strong genetics component, including variation at the level of the genome, alleles, exome, and quantitative trait loci, and it also notes co-study with adaptor proteins involved in signal transduction. Human organ-on-chip systems are described as tools to model disease physiology and pathophysiology for rare genetic disorders.

Genetic factors are supported by the grounding as important contributors to rare diseases. Beyond this, the supplied material does not support generalizable risk factors across the category.

Treatment is not uniform across rare diseases because the category is heterogeneous. The supplied reviews support therapy development using modalities such as AAV-based gene therapies for genetic disorders and human organ-on-chip systems for disease modelling and drug development. More broadly, the literature emphasizes challenges in diagnosis and treatment rather than a single standard therapeutic class.